• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An important oversight in the World Health Organization diagnostic classification: chronic myeloid leukemia with the fusion clone.

作者信息

Wang Jieyu, Wang Shixuan, Xiao Zhiwen, Chen Zhiwei, Qi Ling, Song Baoquan, Wang Jianxiang, Li Fei

机构信息

Jiangxi Provincial Key Laboratory of Hematological Diseases, Department of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi.

National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.

出版信息

Haematologica. 2024 Dec 1;109(12):4120-4124. doi: 10.3324/haematol.2024.285562.

DOI:10.3324/haematol.2024.285562
PMID:39113650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11609777/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/11609777/3f188c8a8c34/1094120.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/11609777/5a1e1f6a154b/1094120.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/11609777/3f188c8a8c34/1094120.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/11609777/5a1e1f6a154b/1094120.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/11609777/3f188c8a8c34/1094120.fig2.jpg

相似文献

1
An important oversight in the World Health Organization diagnostic classification: chronic myeloid leukemia with the fusion clone.世界卫生组织诊断分类中的一个重要疏忽：伴有融合克隆的慢性髓性白血病。
Haematologica. 2024 Dec 1;109(12):4120-4124. doi: 10.3324/haematol.2024.285562.
2
Optical Genome Mapping Reveals Complex and Cryptic Rearrangement Involving :: Fusion in Acute Promyelocytic Leukemia.光学基因组图谱揭示急性早幼粒细胞白血病中涉及::融合的复杂和隐匿性重排。
Genes (Basel). 2024 Oct 30;15(11):1402. doi: 10.3390/genes15111402.
3
Analytical study of , , , , and in Mexican children with acute myeloid leukemia: A multicenter study of the Mexican interinstitutional group for the identification of the causes of childhood leukemia (MIGICCL).墨西哥急性髓系白血病患儿中[具体物质或因素未列出]、[具体物质或因素未列出]、[具体物质或因素未列出]、[具体物质或因素未列出]及[具体物质或因素未列出]的分析研究：墨西哥儿童白血病病因识别机构间小组（MIGICCL）的多中心研究
Front Pediatr. 2022 Nov 14;10:946690. doi: 10.3389/fped.2022.946690. eCollection 2022.
4
Rapid Detection of Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling.急性早幼粒细胞白血病中融合基因的快速检测：采用自适应采样的CRISPR/Cas9纳米孔测序技术
Biomolecules. 2024 Dec 13;14(12):1595. doi: 10.3390/biom14121595.
5
Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.急性髓系白血病和急性早幼粒细胞白血病中的协同白血病发生揭示了C/EBPα是TRIB1和PML/RARA的共同靶点。
Haematologica. 2016 Oct;101(10):1228-1236. doi: 10.3324/haematol.2015.138503. Epub 2016 Jul 6.
6
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies.在急性早幼粒细胞白血病中观察到的典型、非典型和隐匿性 t(15;17)(q24;q21)(PML::RARA)：同时进行染色体和 PML::RARA 双色双融合 FISH 研究的 831 例患者的回顾性分析。
Genes Chromosomes Cancer. 2022 Oct;61(10):629-634. doi: 10.1002/gcc.23070. Epub 2022 Jun 10.
7
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.PML-RARA转基因小鼠白血病中反复出现的染色体异常与人类急性早幼粒细胞白血病相似。
Blood. 2002 Apr 15;99(8):2985-91. doi: 10.1182/blood.v99.8.2985.
8
Acute promyelocytic leukemia with (bcr1, bcr2 and bcr3) transcripts in a pediatric patient.一名儿科患者中存在（bcr1、bcr2和bcr3）转录本的急性早幼粒细胞白血病。
Oncol Lett. 2024 Jan 22;27(3):114. doi: 10.3892/ol.2024.14246. eCollection 2024 Mar.
9
Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.隐匿性PML-RARA易位的微阵列、基因测序及逆转录聚合酶链反应分析
Cancer Genet. 2012 Oct;205(10):537-40. doi: 10.1016/j.cancergen.2012.07.017. Epub 2012 Sep 13.
10
PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.早幼粒细胞白血病-维甲酸受体α融合蛋白需要DNA甲基转移酶3A来引发急性早幼粒细胞白血病。
J Clin Invest. 2016 Jan;126(1):85-98. doi: 10.1172/JCI82897. Epub 2015 Nov 23.

本文引用的文献

1
[Rapid promyelocytic blast crisis of chronic myeloid leukemia with PML-RARα fusion gene: a case report and literature review].[慢性髓系白血病伴PML-RARα融合基因的急早幼粒细胞白血病母细胞危象：一例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):512-515. doi: 10.3760/cma.j.issn.0253-2727.2023.06.014.
2
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。
Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.
3
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
4
Promyelocytic Blast Phase of Chronic Myeloid Leukemia, -Positive: Points to be Considered at Diagnosis.慢性髓性白血病早幼粒细胞急变期，阳性：诊断时需考虑的要点
Ann Lab Med. 2021 May 1;41(3):328-332. doi: 10.3343/alm.2021.41.3.328.
5
Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia.在慢性髓性白血病早幼粒细胞急变期前8个月可检测到融合转录本。
Case Rep Hematol. 2020 Sep 1;2020:8830595. doi: 10.1155/2020/8830595. eCollection 2020.
6
Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor.一名接受酪氨酸激酶抑制剂治疗的慢性髓性白血病患者发生早幼粒细胞白血病母细胞危象。
Cureus. 2020 Mar 9;12(3):e7217. doi: 10.7759/cureus.7217.
7
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.慢性髓性白血病疾病进展和酪氨酸激酶抑制剂治疗耐药的机制：最新进展。
Int J Mol Sci. 2019 Dec 5;20(24):6141. doi: 10.3390/ijms20246141.
8
Blast phase in chronic myelogenous leukemia is skewed toward unusual blast types in patients treated with tyrosine kinase inhibitors: a comparative study of 67 cases.慢性髓性白血病急变期患者接受酪氨酸激酶抑制剂治疗后，急变类型偏向不常见类型：67例病例的比较研究
Am J Clin Pathol. 2015 Jan;143(1):105-19. doi: 10.1309/AJCPWEX5YY4PHSCN.
9
Successful management with an effective induction regimen followed by allogeneic hematopoietic stem cell transplantation for promyelocytic blast crisis of chronic myelogenous leukemia.
Ann Hematol. 2012 Apr;91(4):621-3. doi: 10.1007/s00277-011-1269-1. Epub 2011 Jun 4.
10
Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.伊马替尼与三氧化二砷联合治疗慢性粒细胞白血病伴t(15;17)的急性早幼粒细胞危象成功。
Leuk Res. 2010 Aug;34(8):e213-4. doi: 10.1016/j.leukres.2010.02.030. Epub 2010 Mar 17.